Researchers flag protein biomarker for aggressive oral cancer

Investigators at the University of Toronto say that the S100A7 protein can be used to flag precancerous oral lesions, precursors to cancer of the mouth, which is a particularly serious threat in Asia. "We are extremely pleased to have identified a protein which can predict which oral dysplastic lesions will transform. This will be a great tool to find out which patients really need closer follow-up, and in time this will lead to better patient survival," says Paul Walfish, director of the Mount Sinai Hospital's Alex and Simona Shnaider Research Laboratory in Molecular Oncology. Story

Suggested Articles

Digital molecule designer Insilico Medicine has launched a new preclinical research program focused on treatments for brain cancer.

Ortho Clinical Diagnostics has launched a new chemistry system to complete its integrated Vitros XT line of laboratory solutions.

Synthetic DNA weaver Twist Bioscience announced a handful of new collaborations this week amidst a $140 million raise from an underwritten offering.